David Hui mainly investigates Internal medicine, Surgery, Immunology, Palliative care and Respiratory disease. David Hui combines subjects such as Gastroenterology, Physical therapy and Intensive care with his study of Internal medicine. His work carried out in the field of Surgery brings together such families of science as Sleep apnea, Obstructive sleep apnea, Risk factor and Polysomnography.
David Hui has included themes like Respiratory tract infections and Coronavirus in his Immunology study. His Palliative care study integrates concerns from other disciplines, such as Cancer, Family medicine and Quality of life. His Respiratory disease study also includes fields such as
Internal medicine, Palliative care, Intensive care medicine, Cancer and Physical therapy are his primary areas of study. His study in Internal medicine is interdisciplinary in nature, drawing from both Surgery and Oncology. In his study, Immunology is strongly linked to Respiratory disease, which falls under the umbrella field of Surgery.
The various areas that he examines in his Palliative care study include Advanced cancer and Family medicine, Referral. The Cancer study combines topics in areas such as Pediatrics and Opioid. While the research belongs to areas of Physical therapy, David Hui spends his time largely on the problem of Randomized controlled trial, intersecting his research to questions surrounding Anesthesia, Placebo and Clinical trial.
His scientific interests lie mostly in Internal medicine, Palliative care, Coronavirus disease 2019, Cancer and Severe acute respiratory syndrome coronavirus 2. His work in Internal medicine addresses subjects such as Gastroenterology, which are connected to disciplines such as Liver injury. The concepts of his Palliative care study are interwoven with issues in Delirium, Intensive care medicine and Family medicine, Referral.
His work is dedicated to discovering how Coronavirus disease 2019, 2019-20 coronavirus outbreak are connected with Global health and other disciplines. His Severe acute respiratory syndrome coronavirus 2 research incorporates elements of Environmental health, Virology, Coronavirus Infections, Viral therapy and Serology. His Coronavirus Infections research is multidisciplinary, incorporating elements of International Health Regulations and Viral Epidemiology.
David Hui focuses on Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, 2019-20 coronavirus outbreak, Pandemic and Virology. David Hui has researched Severe acute respiratory syndrome coronavirus 2 in several fields, including Viral transmission, Viral therapy, Coronavirus Infections and Environmental health. His Coronavirus Infections research incorporates themes from International Health Regulations and Viral Epidemiology.
His Betacoronavirus study in the realm of Coronavirus disease 2019 interacts with subjects such as Public interest. The concepts of his Pandemic study are interwoven with issues in Outbreak and Intensive care medicine. The various areas that David Hui examines in his Virology study include Serology and Coronavirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical Characteristics of Coronavirus Disease 2019 in China
Wei-jie Guan;Zheng-yi Ni;Yu Hu;Wenhua Liang.
The New England Journal of Medicine (2020)
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Nelson Lee;David Hui;Alan Wu;Paul Chan.
The New England Journal of Medicine (2003)
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.
David S. Hui;Esam Ei Azhar;Tariq A. Madani;Francine Ntoumi.
International Journal of Infectious Diseases (2020)
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.
Edgar Bautista;Tawee Chotpitayasunondh;Zhancheng Gao.
The New England Journal of Medicine (2010)
Coronaviruses - drug discovery and therapeutic options.
Alimuddin Zumla;Jasper F. W. Chan;Esam I. Azhar;David S. C. Hui.
Nature Reviews Drug Discovery (2016)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.
C. K. Wong;C. W. K. Lam;A. K. L. Wu;W. K. Ip.
Clinical and Experimental Immunology (2004)
Middle East respiratory syndrome.
Alimuddin Zumla;David S Hui;Stanley Perlman.
The Lancet (2015)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Jason D. Goldman;David C.B. Lye;David S. Hui;Kristen M. Marks.
The New England Journal of Medicine (2020)
Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ, IL-4, IL-10 and IL-13) in patients with allergic asthma
C. K. Wong;C. Y. Ho;F. W. S. Ko;C. H. S. Chan.
Clinical and Experimental Immunology (2001)
Haematological manifestations in patients with severe acute respiratory syndrome : retrospective analysis
Raymond S M Wong;Alan Wu;K F To;Nelson Lee.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: